Modifying disease therapy in multiple sclerosis and breast cancer: case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Modifying disease therapy in multiple sclerosis and breast cancer: case report ; volume:82 ; number:S 01 ; year:2024 ; 01
Konferenz: 25th BCTRIMS Annual Meeting; 2024-06-05; Tivoli Mofarrej São Paulo - SP
Arquivos de neuro-psiquiatria ; 82, Heft S 01 (2024), 01
- Beteiligte Personen und Organisationen
-
Nascimento, Felipe
Pereira, Rodrigo
Rios, Marianela
Almeida, Danilo
Araújo, Thiago
Chamma, Pedro
Mansur, Leticia
Pimentel, Maria Lucia Vellutini
- DOI
-
10.1055/s-0044-1789386
- URN
-
urn:nbn:de:101:1-2412121020511.979152415940
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nascimento, Felipe
- Pereira, Rodrigo
- Rios, Marianela
- Almeida, Danilo
- Araújo, Thiago
- Chamma, Pedro
- Mansur, Leticia
- Pimentel, Maria Lucia Vellutini
Ähnliche Objekte (12)
Multiple sclerosis: disease modifying therapy and the human leukocyte antigen
Current Disease-Modifying Therapies in Multiple Sclerosis
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis
Early high-efficacy disease-modifying therapy in multiple sclerosis: a 4-year real-world study
Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis
Fingolimod Therapy for Multiple Sclerosis
Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study
Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
Multiple sclerosis: disease modifying therapy and the human leukocyte antigen
Current Disease-Modifying Therapies in Multiple Sclerosis
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis
Early high-efficacy disease-modifying therapy in multiple sclerosis: a 4-year real-world study
Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis
Fingolimod Therapy for Multiple Sclerosis
Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study
Multiple sclerosis disease-modifying drug use by immigrants: a real-world study
Multiple sclerosis: disease modifying therapy and the human leukocyte antigen
Current Disease-Modifying Therapies in Multiple Sclerosis
Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy
Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis
Early high-efficacy disease-modifying therapy in multiple sclerosis: a 4-year real-world study
Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis
Fingolimod Therapy for Multiple Sclerosis
Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis
Robust real-world evidence: optimising disease-modifying treatments for multiple sclerosis
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study